Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
Amérique du Nord
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
TESLA, INC.
AMAZON.COM, INC.
APPLE INC.
META PLATFORMS, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
All our stock picks
North America
Europe
Asia
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Momentum stocks
Growth stocks
Undervalued stocks
ESG stocks
Trend-Following Stocks
Quality stocks
Investment Themes
Homepage
Robotics
Ageing Population
Strategic Metals
Let's all cycle!
US Basketball
The Golden Age of Video Games
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
The Vegan Market
Water
Let's all cycle!
The future of mobility
Ageing Population
The SPAC
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United States
Nyse
Johnson & Johnson
News
Summary
JNJ
US4781601046
JOHNSON & JOHNSON
(JNJ)
Add to my list
Report
Delayed Nyse -
04:00:02 2023-03-31 pm EDT
155.00
USD
+1.02%
03/30
Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
AQ
03/30
Janssen Provides Portfolio Update
AQ
03/29
Sector Update: Health Care Stocks Steady Late Wednesday
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about JOHNSON & JOHNSON
03/30
Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30
Janssen Provides Portfolio Update
AQ
03/29
UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/29
Johnson & Johnson Unit to Discontinue Respiratory Syncytial Virus Vaccine Program in Ad..
MT
03/23
Janssen Pharmaceutical Says Health Canada Authorizes Expanded Use of Imbruvica in Combi..
MT
03/22
Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
03/20
The Texas Two-Step Is Alive And Well
AQ
03/20
Janssen Pharmaceutical - TREMFYA Real-World Data Analyses Show Greater Treatment Persis..
AQ
03/15
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
BU
03/15
Johnson & Johnson Unit Janssen Says Pre-Clinical Results Showed Dengue Candidate Drug D..
MT
03/15
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Pub..
BU
03/15
Johnson & Johnson Receives Shareholder Proposal from Mercy Investment Services Inc
CI
03/15
Johnson & Johnson Receives Shareholder Proposal from Vermont Pension Investment Commiss..
CI
03/15
Johnson & Johnson Receives Shareholder Proposal from Oxfam America Inc
CI
03/15
Johnson & Johnson Receives Shareholder Proposal from Hal Scott/The Doris Behr 2012 Irre..
CI
More most relevant news
All news about JOHNSON & JOHNSON
03/30
Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30
Janssen Provides Portfolio Update
AQ
03/29
Sector Update: Health Care Stocks Steady Late Wednesday
MT
03/29
Sector Update: Health Care Stocks Mixed on Wednesday Afternoon
MT
03/29
UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/29
Johnson & Johnson Unit to Discontinue Respiratory Syncytial Virus Vaccine Program in Ad..
MT
03/29
STAAR Surgical Appoints Warren Foust as Chief Operating Officer
MT
03/29
Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
AQ
03/23
Janssen Pharmaceutical Says Health Canada Authorizes Expanded Use of Imbruvica in Combi..
MT
03/22
Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
More news
News in other languages on JOHNSON & JOHNSON
03/29
Mise à jour sectorielle : Les valeurs de la santé restent stable..
03/29
Mise à jour sectorielle : les titres du secteur de la santé sont..
03/29
J&J : Janssen abandonne son projet de vaccin contre le RSV
03/29
Johnson & Johnson Unit interrompt son programme de vaccination des adultes contre le vi..
03/29
STAAR Surgical nomme Warren Foust au poste de directeur des opérations
03/23
Janssen Pharmaceutical annonce que Santé Canada autorise l'utilisation élargie d'Imbruv..
03/17
J&J : résultats positifs pour Tremfya contre le psoriasis
03/15
Janssen, une unité de Johnson & Johnson, déclare que les résultats précliniques montren..
03/15
Halozyme Therapeutics réaffirme ses prévisions de recettes pour 2023 après la révocatio..
03/15
Johnson & Johnson reçoit une proposition d'actionnaire de Hal Scott/The Doris Behr 2012..
More news
Analyst Recommendations on JOHNSON & JOHNSON
03/29
UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/01
Guggenheim Initiates Johnson & Johnson at Neutral With $161 Price Target
MT
01/25
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From $176, Maintains E..
MT
01/25
Atlantic Equities Adjusts Johnson & Johnson's Price Target to $168 From $160, Keeps Neu..
MT
01/20
SVB Securities Adjusts Price Target on Johnson & Johnson to $186 From $194, Maintains O..
MT
More recommendations
Press releases
03/30
Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30
Janssen Provides Portfolio Update
AQ
03/29
Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
AQ
03/22
Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
03/20
The Texas Two-Step Is Alive And Well
AQ
More press releases
Powered by Scoopnest.com
Analysis
J&J CEO Joaquin Duato to take additional role of Chairman
More Must read
Upcoming event on JOHNSON & JOHNSON
04/18/23
Q1 2023 Earnings Call
Company calendar
Upcoming sector events
04/27/23
ABBVIE INC. : Q1 2023 Earnings Release (Projected)
04/27/23
ELI LILLY AND COMPANY : Q1 2023 Earnings Release
04/27/23
MERCK & CO., INC. : Q1 2023 Earnings Release
05/04/23
NOVO NORDISK A/S : Q1 2023 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
Slave